ABSTRACT Gene therapy targeted to vascular cells represents a promising approach for prevention and treatment of pathological conditions such as intimal hyperplasia, in-stent and post-angioplasty restenosis. In this context, polymeric non-viral gene delivery systems are a safe alternative to viral vectors but a further improvement in efficiency and cytocompatibility is needed to improve their clinical success. Herein, a library of 24 branched polyethylenimine (bPEI) derivatives modified with hydrophobic moieties was synthesised, characterised and tested in vitro on primary vascular cells, aiming to identify delivery agents with superior transfection efficiency and low cytotoxicity. Low molecular weight PEIs (0.6, 1.2 and 2 kDa) were grafted with long (C18) and short (C3) aliphatic chains, featuring different unsaturation degrees and degrees of substitution. 0.6 kDa bPEI-based derivatives were generally ineffective in transfection on vascular smooth muscle cells (VSMCs), while among the other derivatives some promising vectors were identified. Forcing polyplexes on the cell surface by means of centrifugation invariably boosted transfection levels but increased cytotoxicity as well. Of note, a propionyl-substituted derivative (PEI2-PrA1, C3:0) was the most effective on both VSMCs and endothelial cells (ECs), with higher and more sustained gene expression in combination with markedly lower cytotoxicity with respect to the gold standard 25 kDa bPEI. In addition, a linoleoyl-substituted derivative (PEI1.2-LA6, C18:2) owing to its high efficiency in VSMCs and relative inefficacy in ECs, combined with tolerable cytotoxicity was proposed as a vector for specific VSMCs targeting.
INTRODUCTION
Cardiovascular diseases are the leading cause of death worldwide [1] . Consequently, vascular interventions represent one of the most common surgical procedures, whose numbers are predicted to further increase owing to the growth of the elderly demographic of the population [2] . Proliferation, migration and phenotype switch of vascular smooth muscle cells (VSMCs) play pivotal roles in several pathological vascular conditions such as intimal hyperplasia and are crucial events leading to in-stent and post-angioplasty restenosis [3] . In addition, endothelial cells (ECs) are strongly involved in these phenomena since they are responsible for endothelial regeneration and can regulate VSMC proliferation and phenotypic switch [4] . In this context, gene therapy targeted to VSMCs and ECs is a promising therapeutic approach for the targeted inhibition of mechanisms leading to the development of vascular pathologies or to post-intervention complications [5] . Furthermore, in vitro gene delivery to primary VSMCs and ECs can be employed for tissue engineering and regeneration applications [6] , and in the study of gene function and of the general physiology of vascular tissues [7] .
Gene therapy involves the therapeutic introduction of DNA or RNA into cells with the goal of modifying their protein expression profile and halting disease progression. However, the efficient and safe delivery of nucleic acids to cells is still a key challenge towards the clinical application of gene therapy. Traditional gene delivery techniques used in laboratory are in fact difficult to effectively translate to in vivo [8] . Viral vectors are generally considered to be the most efficient gene delivery systems, but their use is limited by the immune response exerted by the body and other major safety concerns. Chemical non-viral vectors represent a safer alternative, but further improvement of their efficiency, especially in primary cells, is still a key point to clinical success. Among non-viral vectors, cationic polymers display distinct advantages in terms of reproducibility, high degree of molecular diversity and of easiness of chemical functionalization that allows fine-tuning of their physicochemical properties and performance [9] . When exposed to polyanionic DNA, cationic polymers self-assemble into positively charged polymer/DNA complexes, named polyplexes, that protect nucleic acids from degradation and mediate their cellular uptake. Polyethyleneimine (PEI) is recognised as the gold standard polymeric gene carrier; it features a high charge density and a strong buffering capacity at acidic pH that elicits endosomal escape of PEI-based polyplexes via a process named "proton sponge effect" [10] . It is worth to note that high molecular weight (MW) PEIs display not only higher transfection efficiency but also greater cytotoxicity with respect to their low MW counterparts. To improve its efficacy and cytocompatibility, PEI has been chemically tailored with a number of different substituents [9, 11, 12] , among which, hydrophobic modification has been proven as a valuable approach. In fact, the grafting of hydrophobic chains on PEI results in increased cellular uptake via endocytosis and improved interactions between polyplexes and cell membranes [13] . These strategies mainly rely on the functionalization of cytocompatible low MW PEI with hydrophobic moieties to improve transfection efficiency, while retaining limited cytotoxicity. A number of different substitutes have been successfully grafted to PEI thus far: cholesterol [14] , cholic acid, long-chain dodecyl and hexadecyl moieties [15] , lipoic acid [16] , saturated and unsaturated lipids of different lengths such as palmitic acid, stearic acid, oleic acid, and linoleic acid [13, 17, 18] and, recently, the small hydrophobic propionic acid [19] .
In light of the promising results about hydrophobic moiety-substituted PEI and given the importance of developing safe and effective vectors for the transfection of VSMCs and ECs, in this study we explored and compared the potential of a library of hydrophobe-substituted branched PEI (bPEI) derivatives to transfect these two cell types. Low MW bPEIs (0.6, 1.2 and 2 kDa) were employed as backbone for the synthesis of the derivatives and five hydrophobic substituents were grafted at different grafting degrees aiming to finally identify the best transfection reagents and possibly draw structure-activity relationships. 
EXPERIMENTAL SECTION

Materials
Polymer synthesis and characterization
Hydrophobe-modified bPEI derivatives were prepared by grafting hydrophobic molecules onto bPEIs via N-acetylation as described earlier [17] . In a typical experiment, a lipid chloride (2 mmol L −1 ) and PEI (1 mmol L −1 ) were dissolved separately in ice-cold anhydrous chloroform for 30 min. Triethylamine (100 µL) was added to the PEI solution and cooled for another 30 min in ice bath. The lipid chloride solution was added dropwise to the PEI solution while being kept on ice bath under stirring. Reaction mixture was then left stirring overnight (~12 h) at room temperature. Derivatives with propionic acid (PrA) and acryloyl chloride (AoCl) were prepared using EDC/NHS activation method as described in our earlier publication [19] . The crude product was precipitated 3 times in ice-cold diethylether and dried under vacuum for 2 days. The structural composition of the polymers was analyzed by 1 H-NMR spectroscopy (Bruker 300MHz, Billerica, MA, USA) using tetramethylsilane as an internal standard in D2O to calculate the lipid substitution levels, which are summarized in Table 1 .
Preparation of polyplexes
Polyplexes were prepared at room temperature by adding an aqueous solution of pDNA (0.4 μg μL −1 ) to the bPEI derivatives diluted in serum-free medium (Opti-MEM) at the desired concentration (polymer solution), to obtain different polymer/pDNA w/w ratios. The final pDNA concentration in the polyplex suspensions was 25 ng μL −1 . Polyplex suspensions were incubated for 30 min at room temperature prior to use in transfection studies.
DNA binding by polymers
The ability of bPEI derivatives to bind and complex DNA was evaluated by a fluorophore-exclusion assay using SYBR Green I (λex = 497 nm; λem = 520 nm) as DNA dye [20] . Polyplexes (400 ng of pDNA per condition) were prepared in serum-free medium at different w/w ratios as described above. Polyplexes were next diluted to 100 μL in 10 mmol L −1 HEPES (pH 7.0) containing 2× DNA dye and, after further 20 min incubation at room temperature, fluorescence was measured in a black 96-well microplate. The fluorescence of the samples was normalized over the signal of free pDNA. For each polymer, fluorescence % was plotted against polymer/pDNA w/w ratio and fitted to a sigmoidal curve that was used to calculate the BC50 (w/w ratio requi- 
Size and ζ-potential of polyplexes
The hydrodynamic diameter (DH) and the ζ-potential (ζP) of bPEI derivatives/pDNA complexes were measured through dynamic light scattering (DLS) and laser Doppler micro-electrophoresis using a Malvern Zetasizer Nano-ZS (Malvern Instruments, Malvern, UK) equipped with He-Ne laser and operated at 10 mW. Polyplexes were prepared at different w/w as described above and measured after equilibration at 25°C.
Cells and cell culture
Primary Porcine Aortic SMCs (PAoSMCs) were derived from tunica media of healthy, fibrous plaque-free porcine arteries. Briefly, PAoSMCs were isolated from 1 cm wide aortic rings cut from the aorta of a pig. Aortic segments were collected in PBS, placed in M199 medium supplemented with 1% penicillin/streptomycin solution and immediately dissected. The adventitia tissue and the first external third of the media were carefully removed and the resulting rings were cut in small pieces of approximately 1 mm × 5 mm using a scalpel and moved into a Petri dish containing M199 medium supplemented with 10% FBS and 1% penicillin/streptomycin solution (complete M199, hereafter referred to as cM199). Medium was changed every other day. The explants were removed after one week when a sufficient amount of SMCs was present on the surface of the Petri dish. PAoSMCs were then cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin solution (complete DMEM, hereafter referred to as cDMEM) at 37°C in a humidified atmosphere of 5% CO2. Primary Human Umbilical Artery SMCs (HUASMCs) were purchased from Lonza (CC-2579, Walkersville, MD, USA) and cultured at 37°C in a humidified atmosphere under constant supply of 5% CO2, in cDMEM enriched with 5 μg mL −1 human insulin (Santa Cruz Biotechnology, Dallas, TX), 2 ng mL −1 fibroblast growth factor-basic (FGFb, Gibco by Life Technologies, Grand Island, NY, USA), and 0.5 ng mL −1 epidermal growth factor (EGF, Invitrogen by Life Technologies), hereafter referred to as cDMEM+.
Primary Human Umbilical Vein Endothelial Cells (HUVECs) were isolated from~15 cm-long umbilical cord pieces obtained from normal-term pregnancies with the consent of the donor mothers. Briefly, the vein was rinsed with PBS, filled with 10× trypsin-EDTA solution (Gibco by Life Technologies) and incubated for 15 min at 37°C. Then the trypsin-EDTA solution containing cells was collected, PBS was added to wash the lumen of the vein, collected and added to the cell-containing suspension. The resulting cell suspension was centrifuged at 1,000 rpm for 5 min, the supernatant was removed and cells were resuspended in cM199 and seeded in a T75 flask. Culture medium was changed after 24 h and then every 48 h until confluence. ECs were cultured in cM199 supplemented with 2 ng mL −1 FGFb, 0.5 ng mL −1 EGF, 1 µg mL −1 L-ascorbic acid (Sigma-Aldrich), 5 µg mL −1 human insulin, 1 µg mL
hydrocortisone (Sigma-Aldrich) and 90 µg mL −1 porcine heparin sodium salt Grade I-A (Sigma-Aldrich), hereafter referred to as cM199+.
The protocols for the isolation of PAoSMCs and HUVECs were approved by the Ethics Committee of CHU de Québec Research Centre. For all the experiments cells were used at passage between 6 and 10.
In vitro transfection experiments
Twenty-four hours before transfection experiments PAoSMCs, HUASMCs and HUVECs were seeded in 96-well cell culture plates at a density of 2.0 × 10 4 cells/cm 2 in the corresponding culture medium (cDMEM, cD-MEM+ and cM199+, respectively). Twenty-four hours post-seeding, 160 ng/well (PAoSMCs) or 80 ng/well of pDNA (HUASMCs and HUVECs) were complexed with bPEI derivatives at the desired w/w and added to cells in fresh complete medium. The final pDNA concentration in the culture medium was 1 μg mL −1 . Four hours after the addition of polyplexes, the transfection medium was replaced with 100 μL of fresh culture medium. When indicated, cells were centrifuged at 500 ×g for 5 min immediately after the addition of polyplexes.
Evaluation of cytotoxicity and transfection efficiency
The cytotoxicity of polyplexes was assessed by AlamarBlue cell viability assay. The medium was harvested and replaced with 100 μL of complete medium containing 10% AlamarBlue solution. Cells were incubated in standard culture conditions for 3 h and the fluorescence of the medium (λex = 560 nm; λem = 590 nm) was read using the SpectraMax i3x microplate reader. Viability of non-treated control cells was assigned to as 100% and cytotoxicity was determined as follows:
Cytotoxicity [%] = 100% − Viability [%]. The expression of firefly luciferase (pGL3 plasmid) was evaluated 48 h post-transfection by measuring the luciferase activity using the Luciferase Assay System as previously described [21] . Briefly, cells were washed with PBS, lysed with 0.25× Cell Culture Lysis Reagent (Promega) and freeze-thawed once. Then, 20 μL of cell lysate were mixed with 50 μL of Luciferase Assay Reagent and luminescence was immediately recorded by the microplate reader. The chemiluminescence signal of the samples was normalized to their corresponding protein content, determined by BCA assay. Data were finally expressed as relative light units per mg of proteins (RLU/mg of proteins).
The expression of Gaussia luciferase (pGLuc plasmid), secreted in the culture medium, was assessed at different time points by BioLux Gaussia Luciferase Assay Kit, according to manufacturer's instructions. Culture medium was harvested 24 h post-transfection or 24 h after every medium change and 20 μL of medium were mixed with 50 μL of GLuc assay solution and luminescence was promptly measured by the microplate reader.
Statistical analysis
Results were expressed as mean ± standard deviation. Statistical analyses were carried out by means of GraphPad Prism v 6.01 (GraphPad software, La Jolla, CA, USA). Comparisons among groups were performed by one-way analysis of variance (ANOVA) with Sidak-Bonferroni adjustment for multiple testing. Correlations were evaluated by Pearson correlation test. Significance was retained when p < 0.05.
RESULTS AND DISCUSSION
Primary vascular cells, SMCs and ECs, as many other primary cells, are recognised difficult-to-transfect cell types [22] [23] [24] . In this study we investigated the efficiency of hydrophobe-substituted bPEI derivatives in the transfection of these cells. Different fatty acid-based substitutes have been investigated, namely stearic acid (St, C18 chain), linoleic acid (LA, C18:2 (6, 9) chain), and propionic acid (PrA, C3 chain), already reported to improve the transfection activity of bPEI on other cell types such as human embryonic kidney cells (293T) [17] , rat bone marrow stromal cells (rBMSC) [25] and human breast cancer cells (MDA-231 and MCF-7) [19] . Besides, two new families of bPEI derivatives, carrying α-linoleic acid (αLA, C18:3 (3, 6, 9) chain) and acrylic acid (AcA, C3:1 (1) chain), were synthesised and studied, aiming to evaluate whether an increase in the level of unsaturation in the aliphatic chain of linoleoyl-and propionyl-based substitutes (i.e., an additional double bond, in position 3 and 1, respectively) could lead to a further enhancement in the transfection efficiency of bPEI derivatives on vascular cells. Of note, to find out the optimal chemical structures and to draw overall structure-activity relationships, different bPEI backbone MWs and degrees of substitution were tested. [17, 19] ; the reaction feed ratio and the resulting degree of substitution, as measured by 1 H-NMR, of the resulting polymers are reported in Table 1 . As expected, the degree of substitution increased by increasing the feed ratio for every lipid, to give an average yield between 0.54 and 0.56 for all the substituents except St and LA that displayed a significantly lower average yield of 0.37 and 0.38 respectively. Every bPEI derivative was water soluble.
Synthesis and characterization of hydrophobe-substituted
bPEI derivatives Chemical strategies previously optimised for lipid substitution on bPEI were herein employed for the derivatization of 0.6, 1.2 and 2 kDa bPEI with St, LA, αLA, PrA and AcA (Scheme 1)
DNA complexation ability of bPEI derivatives and polyplex characterization
The capacity of every polymer to bind and complex pDNA was evaluated by SYBR Green I-exclusion assay. SYBR Green I is a non-specific intercalating DNA dye with high fluorescence quantum yield and a strong fluorescence enhancement when bound to DNA that has been commonly used to investigate DNA complexation [20] . Representative complexation curves as a function of polymer:DNA ratio (w/w) are shown in Fig. 1a (please see Supplementary information, Fig. S1 for the complexation curves of all the bPEI derivatives) and Table 1 shows the w/w required for 50% pDNA binding (BC50).
All the complexation curves shared a similar sigmoidal decrease in fluorescence as the polymer/pDNA weight ratios were increased. Generally speaking, the complexation ability of bPEI derivatives decreased while increasing the degree of substitution, as indicated by the higher BC50 that reached values higher than 2.5 for PEI2-St12, PEI2-LA9 and PEI2-αLA8. In addition, a general positive and statistically significant correlation was found between BC50 and the degree of substitution for the three bPEI backbones (Fig. 1b, Pearson correlation, p < 0.05 ). This could be explained by the loss of amines available for interaction with negatively charged nucleic acids, owing to amine substitution and to the steric hindrance of the grafted molecules [17] . Dispersity in BC50 values was noted at higher substitutions (> 2 hydrophobes per PEI) for 1.2 kDa bPEI-based derivatives. It is likely that the nature of the hydrophobic moieties became important in this region, differentially affecting nucleic acid binding due to steric hindrance. As the physicochemical properties of polyplexes are expected to strongly affect their activity [26] , the ζP and DH of polymer/pDNA complexes were measured at w/w of 5 and 10, conditions that led to significant activity in transfection experiments; the results for the selected derivatives (the most efficient ones in transfection experiments) are shown in Table 2 , while those relative to every bPEI derivative are reported in the Supplementary information (Table  S1 ). For all the bPEI derivatives, nanometric sizes were observed, with DH always smaller than 300 nm and in general comparable to native bPEIs, except for 0.6 kDa bPEI that yielded relatively large particles bigger than 1 μm. The only exception was PEI2-St12 that already showed the lowest ability to complex DNA (BC50 = 8.088) and formed particles larger than 1 μm at w/w 5 and of ca. 700 μm at w/w 10. ζP was always positive and between +10 mV and +30 mV at both w/w tested, except for PEI1.2-LA6 that showed an almost neutral surface charge at w/w 5. In contrast to BC50, no significant correlation with the degree of substitution was observed for both size and ζP (Pearson correlation, p > 0.05).
Transfection of VSMCs by bPEI derivatives
While the ability to efficiently complex DNA is necessary for gene delivery vectors, it does not guarantee effectiveness in transfection. Therefore, we tested the transfection efficiency and the cytotoxicity of polyplexes prepared at different w/w with b PEI derivatives on primary VSMCs obtained from the human umbilical artery (HUASMCs) and from the porcine aorta (PAoSMCs), since pigs are commonly used in vascular research as a model of human disease [27] . The presence of serum in culture medium is necessary for long-term cell cultures and it is commonly employed to evaluate resistance to serum of gene delivery vectors prior to in vivo tests [28] , consequently, transfection experiments were carried out in cDMEM, containing 10% FBS. Three w/w ratios (2.5, 5 and 10) were tested, given the recognised dependence of transfection activity on this parameter. Culture medium containing polyplexes was replaced with fresh new cDMEM 4 h after transfection and 44 h later, transfection efficiency and cytotoxicity were evaluated. Firefly luciferase was used as a luciferase reporter system (pGL3), enabling a highly sensitive evaluation of transgene expression. It is worth to note that transfection experiments on HUASMCs were performed with a lower dose of polyplexes (80 vs.160 ng of pDNA/well) to avoid massive cytotoxicity. Transfection outcomes on primary PAoSMCs and HUASMCs are shown in Figs 2 and 3 respectively. As expected, a strong dependence on polymer/DNA w/w ratio was observed. A low w/w of 2.5 always led to non-relevant transgene expression (data not shown) while w/w 10 was usually the most effective ratio for bPEI derivatives. The bPEI derivatives synthesised with 0.6 kDa bPEI backbone were generally ineffective in transfecting VSMCs in comparison to their counterparts synthesised from 1.2 or 2 kDa bPEI, suggesting that the substitution with hydrophobic moieties of bPEI featuring too small polymeric backbone (0.6 kDa) was ineffective in producing efficient gene vectors, even if such polymers did complex DNA effectively. No obvious general differences between the 1.2 and 2.0 kDa bPEI backbones could be observed both in terms of transfection efficiency and cytotoxicity, suggesting that both polymers were suitable substrates for hydrophobic substitution.
As expected from DNA complexation results, and as often reported for bPEI derivatives [29] [30] [31] , the degree of substitution strongly influenced the transfection properties. Very high substitution degrees led to low efficiency (PEI2-St12, PEI2-LA9, PEI1.2-αLA6) both in PAoSMCs and HUASMCs. Surprisingly, despite its low DNA complexation ability (BC50 = 3.9), PEI2-αLA8 displayed high transfection levels on PAoSMCs, comparable to its counterparts featuring a lower substitution degree, but negligible activity on HUASMCs. However, no significant direct correlation between transfection efficiency and the extent of lipid substitution was observed for the three bPEI backbones (Fig. S2 , Pearson correlation, p > 0.05). This was quite expected since, as already observed in similar systems [16, 19] , increasing hydrophobic-moiety degree of substitution initially improves transfection until the attainment of an optimum after which efficiency decreases due to the excessive reduction of the number of amines available for DNA condensation.
The cytotoxicity of the polymers was generally lower than 20% on PAoSMCs, and lower than that of 25 kDa bPEI (p < 0.05) for all the derivatives tested, except for PEI1.2-αLA4, which was as toxic as 25 kDa bPEI. In contrast, HUASMCs were much more sensitive to the overall cytotoxicity of transfectants and we thus reduced the polyplex dose delivered to avoid extensive cell death. As often observed in literature [32] , derivatives with negligible activity exerted the lowest cytotoxicity and higher transfection efficiency levels were often associated with increased toxicity. A significant positive correlation between transfection efficiency and cytotoxicity was observed on PAoSMCs ( Even though St-substituted bPEIs have been previously described as good transfection agents for siRNA delivery [13] , our results showed that PEI-St polymers herein investigated were not so effective on both the VSMC types. PEI1.2-LA6 used at w/w 10 was the most effective PEI-LA derivative, as efficient as (p > 0.05) but much less cytotoxic (cytotoxicity: 10.4 ± 2.4% vs. 22.9 ± 4.7%, PEI1.2-LA6 w/w 10 vs. 25 kDa bPEI w/w 5, p < 0.05) than the gold standard polymeric transfectant 25 kDa bPEI on PAoSMCs. PEI1.2-LA6 was still the best LA-based derivative on HUASMCs but it was less efficient than 25 kDa bPEI (p < 0.05) even if less cytotoxic (cytotoxicity: 40.8 ± 3.1% vs. 50.2 ± 2.9%, PEI1.2-LA6 w/w 10 vs. 25 kDa bPEI w/w 5, p < 0.05). Interestingly, LA-substituted 2 kDa bPEI, already reported as one of the best bPEI-lipid derivatives on 293T cells and rBMSC [17] , did not show high transfection levels on VSMCs. These results suggest that the simultaneous fine tuning of the polymeric backbone MW and of the degree of substitution is a very important cell-specific determinant but that the optimized chemical properties are not universal for all cell types.
In line with the results previously reported on MDA-231 and MCF-7 human breast cancer cells [19] , PEI-PrA derivatives displayed high transgene expression especially on HUASMCs. Among them, PEI2-PrA1 was the most effective because the best compromise between high efficiency and low toxicity. In fact, PEI2-PrA1 derivative was as efficient as (p > 0.05) but much less cytotoxic than 25 kDa bPEI (cytotoxicity: 6.3 ± 2.0 % vs. 22.9 ± 4.7 %, PEI2-PrA w/w 10 vs. 25 kDa bPEI w/w 5, p < 0.05) on PAoSMCs. It was also the most effective among the tested derivatives on HUASMCs, with transfection levels more than twice higher than 25 kDa bPEI (p < 0.05) and with significantly lower toxicity (cytotoxicity: 16.4 ± 3.8 % vs. 50.2 ± 2.9 %, PEI2-PrA1 w/w 10 vs. 25 kDa bPEI w/w 5, p < 0.05).
It is worthy of note that an increase in the unsaturation level of the substitute (αLA vs. LA, and AcA vs. PrA) did not lead to an improvement of the transfection activity of the polymers. PEI-αLA and PEI-AcA were invariably less efficient than PEI1.2-LA6 and PEI2-PrA1, respectively, on PAoSMCs (p < 0.05). Only PEI1.2-αLA2 displayed levels of transfection comparable to PEI1.2-LA6 (p > 0.05) on HUASMC, whilst PEI1.2-AcA2, which was by far the most efficient reagent belonging to the PEI-AcA family, showed a three-time lower luciferase expression as compared to PEI2-PrA1. Noteworthy, considering that oleic acid-sub-stituted PEI (degree of unsaturation = 1) already demonstrated a much lower efficiency as nuclei acid delivery agent with respect to PEI-LA [33] and taking into account the results on PEI-St (saturated), PEI-LA (degree of unsaturation = 2) and PEI-αLA (degree of unsaturation = 3), it can be speculated that a degree of unsaturation of 2 is optimal for the substitution of low MW PEIs with the C18 lipids.
In light of these results, PEI1.2-LA6, PEI1.2-αLA2, PEI2-PrA2, and PEI1.2-AcA2 polymers were selected for further investigation.
Effect of centrifugation on the transfection activity of bPEI derivatives on VSMCs
Centrifugation of polyplexes is a simple way to accelerate their settling onto the cell surface, thus immediately increasing their concentration in the proximity of the cells. This approach can improve cellular uptake and the final transfection efficiency [34] . With this in mind, we challenged VSMCs with every selected bPEI derivative subjected to a 5 min-centrifugation at 500 ×g immediately after the addition of polyplexes to the cells. Based on the results reported hereinabove, bPEI derivatives were used at w/w 10, while 25 kDa bPEI at w/w 5. As expected, centrifugation led to a substantial increase of the transfection levels, at least 10 folds higher than non-centrifuged controls (Fig. 4) . The enhancement due to centrifugation was polymer-specific in the case of PAoSMCs, but not for HUASMCs for reasons to be elucidated. Unfortunately, higher cytotoxicity was also associated to the increase in transfection efficiency (p < 0.05, centrifuged vs. non-centrifuged, for every polymer), however, the cytotoxicity of bPEI derivatives was still significantly lower than that of 25 kDa bPEI. These results highlight the importance of sedimentation of gene delivery complexes on the cell surface to optimize transfection, but also strengthen the almost unavoidable relationship existing between increase in gene delivery activity and cytotoxicity.
Transgene expression kinetics of bPEI derivatives in VSMCs
The kinetics of transgene expression for the selected bPEI derivatives was investigated to evaluate the medium-and long-term transfection efficiency on VSMCs. In accordance with the above results, polyplexes were centrifuged on the cells in order to maximise transfection efficiency. The plasmid encoding for the secreted Gaussia luciferase (pGLuc) was used for these studies. This enzyme endowed with chemiluminescent activity is constitutively secreted into the cell culture media that is harvested, allowing for real-time cell monitoring of the reporter gene expression and making easy the measurement of the expression kinetics.
As shown in Fig. 5a and b, a much more sustained transgene expression was generally observed on PAoSMCs with respect to HUASMCs. In the former, 25 kDa bPEI showed a peak of expression within the first 48 h and then abruptly declined to levels nearly two orders of magnitude lower at day 10. However, for the bPEI derivatives, GLuc expression was stable or even increased over the first 4 days post-transfection, thereafter gradually decreasing by one order of magnitude. PEI1.2-LA6 and PEI2-PrA1 were the best performing derivatives. PEI2-PrA1 showed transfection levels comparable to 25 kDa bPEI within the first 4 days and more than 5-fold greater for longer times (p < 0.05, PEI2-PrA1 w/w 10 vs. 25 kDa bPEI w/w 5 at day 10). The improved transfection efficiency over the long run was presumably due to the higher compatibility of low MW PEIs (i.e., the higher percentage of modified cells remaining viable over a long period). In fact, the higher cytotoxicity of 25 kDa bPEI is expected to negatively affect the long-term survival of the pool of cells that were actually transfected, leading to a more prominent decrease of exogenous transgene expression.
A common behaviour was observed for every polymer tested on HUASMC (Fig. 5b) , with the expression maximum occurring at 24 h and a sharp decrease leading to quite steady levels of expression (at least two order of magnitude lower than day 1) after day 4. Of note, PEI2-PrA1 was again the most promising transfectant: transfection efficiency was comparable to that of 25 kDa bPEI within the first 72 h, but superior over the long term (4.6 fold higher values at day 10; p < 0.05, PEI2-PrA1 w/w 10 vs. 25 kDa bPEI w/w 5 at day 10). Altogether, the superior gene expression profiles combined with the lower cytotoxicity with respect to the gold standard 25 kDa bPEI make PEI2-PrA1 a very promising candidate for the transfection of VSMCs. These transfection results are extremely important because they were obtained in the presence of serum and upon centrifugation of the polyplexes over the cells, mimicking the high concentration at the cell surface that could be found in cardiovascular devices such as gene-eluting stents [35] or catheter balloons [36, 37] .
Cytotoxicity and transgene expression kinetics in HUVECs
VSMCs are not the sole cell type playing a role in in-stent and post-angioplasty restenosis. ECs are present on the luminal surface of arteries and represent a suitable therapeutic target to prevent intima hyperplasia by speeding up the formation of a functional endothelium and preventing VSMCs migration and proliferation [38, 39] . With this in mind, the two most promising bPEI derivatives PEI1.2-LA6 and PEI2-PrA1, were used to transfect primary HUVECs and compared to 25 kDa bPEI. The optimised transfection conditions identified with VSMCs were employed and polyplexes were forced to sediment onto cells by centrifugation. A common behaviour in the transgene expression kinetics for every transfectant was apparent, with a maximum expression at day 1, followed by a sharp decrease over time (Fig. 6a) . In line with the results obtained on VSMCs, PEI2-PrA1 displayed an improved and long-lasting transfection in combination with cytotoxicity levels once again lower than 25 kDa bPEI (cytotoxicity: 30.6 ± 6.8% vs. 48.0 ± 9.6%, PEI2-PrA1 w/w 10 vs. 25 kDa bPEI w/w 5, p < 0.05) and it can be thus considered as the most promising hydrophobe-bPEI derivative for the transfection of vascular cells. It is worth noting that, even if PEI1.2-LA6 showed high efficiency on VSMC, it was much less effective on HUVECs compared to both PEI2-PrA1 and 25 kDa bPEI. Due to its specificity towards VSMCs and in consideration of its quite low cytotoxicity, PEI1.2-LA6 could therefore be proposed for the specific targeting of VSMCs in the vascular wall.
CONCLUSIONS
Herein, a library of hydrophobe-substituted low MW bPEI derivatives with different bPEI backbone MWs, degrees of substitution and types of hydrophobic substitutes were investigated as gene delivery vectors for primary VSMCs and ECs. The developed bPEI derivatives were found effective in complexing DNA and, of note, the complexation ability was inversely correlated with the degree of substitution. Such polymers were generally less cytotoxic than the gold standard polymeric transfection reagent 25 kDa bPEI and some of them displayed an equal or even higher transfection efficiency. Very small polymers (i.e., 0.6 kDa bPEI- based derivatives) were ineffective in transfection, while among 1.2 and 2 kDa bPEI-derivatives, the propionic acidsubstituted polymer PEI2-PrA1 was the most promising compound for VSMCs transfection. Due to the increase of polyplex sedimentation on the cell surface, centrifugation of polyplexes over the cells greatly improved transfection efficiency. It is worth noting that in this experimental setup, mimicking the high polyplex concentration occurring in cardiovascular devices such as gene-eluting stents or catheter balloons, the activity of PEI2-PrA1 was higher and more sustained than 25 kDa bPEI on both VSMCs and ECs, while maintaining significantly lower cytotoxicity levels. Interestingly, the linoleic acid-substituted polymer PEI1.2-LA6 was at least as effective as and less cytotoxic than 25 kDa bPEI on VSMCs but exerted low transfection on ECs, suggesting that this polymer could be used for the selective gene delivery to VSMCs in blood vessels. Altogether, in this work, hydrophobic moiety-substituted low MW bPEI derivatives with superior transfection properties on vascular cells were identified, with possible applications in non-viral gene therapy approaches aimed at the targeted inhibition of vascular pathologies such as intimal hyperplasia and in-stent/post-angioplasty restenosis.
